$ARX

ONeill Francis James sold $2.1M of ARX (indirect holdings)

ONeill Francis James (Co-Founder, Chief U/W Officer) sold 165,886 indirectly-held shares of Accelerant Holdings (ARX) at an average of $12.78 ($12.71–$12.84, $2.12M total) across 2 trades over 2026-07-14 to 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · ONeill Francis James
Published Jul 17, 2026, 12:27 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 17, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ARX
Neutral
high confidence
Mentioned
$ARX
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARXNeutralLow
01

Why it matters

The newest fact is the disclosed sale size ($2.12M) and the fact it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor insider activity for sentiment, but 10b5-1 plans usually carry less informational weight than unscheduled sales.

03

What to watch

The filing does not disclose reasons for the sale, and the net ownership after the transaction remains large, reducing interpretability for near-term fundamentals.

Relevance 5/10Novelty 2/10Timing: Filed 2026-07-16 for sales executed 2026-07-14 to 2026-07-15.

Background

The article is an SEC Form 4 insider transaction disclosure for Accelerant Holdings (ARX).

Company-level read

Ticker impact

$ARXNeutralHigh confidence
Context

Form 4 shows co-founder and Chief U/W Officer ONeill Francis James sold $2.12M of ARX via a 10b5-1 plan across two trades.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a routine Form 4 disclosure with explicit 10b5-1 pre-arrangement and no accompanying company-specific operational or financial catalyst.

Market effects

No sector read-through; this is company-specific insider transaction reporting.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than a bearish view on ARX.

Key entities

  • Accelerant Holdings

    Subject of the Form 4 insider sale disclosure (ARX).

  • ONeill Francis James

    Co-Founder and Chief U/W Officer who sold ARX shares via open-market transactions under a 10b5-1 plan.

Related articles

$ARXMed

ARX: Q2 2026 delivered robust operational and financial results, with the Shell acquisition progressing

Less than 1 min read Q2 2026 saw strong production growth and higher realized prices, driving a 20% year-over-year increase in funds from operations and a 94% rise in free funds flow per share. Net income declined 9% per share due to lower risk management gains and higher costs. The pending $22 billion Shell acquisition remains on track. Original document: ARC Resources Ltd. [ARX] Interim report — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies.

$ARXMed

ARX: Q2 2026 delivered robust production and cash flow as the $22B Shell acquisition advances

Less than 1 min read Q2 2026 saw 9% year-over-year production growth and strong cash flow, with $816 million in funds from operations and $349 million in free funds flow. The $22 billion Shell acquisition is progressing, with closing expected in Q3 2026. Original document: ARC Resources Ltd. [ARX] Earnings Release — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

$ARXMed

Accelerant Holdings Stock Rises 10%

Accelerant Holdings (ARX) shares rose 9.73% to $12.86 on Wednesday after the company said it expanded a partnership with Incline P&C Group. Effective July 1, 2026, Incline will act as a fronting carrier for over $500 million in annual gross written premiums across Accelerant’s U.S. commercial specialty insurance portfolio.

$ARXMedAI 8/10

Oil Volatility Is Back: 3 Canadian Stocks to Buy Now

The article says oil and gas prices remain volatile and highlights three Canadian energy stocks. Tourmaline Oil (TOU) reported record Q1 production and expects higher free cash flow in 2026-27, planning a $0.50 quarterly base dividend (yield ~3.1%). Birchcliff (BIR) reported strong Q1 2026 results and a $0.03 quarterly dividend. ARC Resources (ARX) reported Q1 2026 net income of $584m ($1.03/share) and agreed to be acquired by Shell in a ~$16.4bn deal including debt.